NBP
NovaBridge Biosciences
1.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.6% | 89.4% | 89.4% | 90.8% | 80.9% | 83.1% | 82.9% | 81.1% | 83.9% | 83.5% | 85.5% | 85.5% | |
| 67.2% | 82.0% | 86.1% | 59.9% | 34.1% | 32.1% | 25.7% | 80.0% | 82.2% | 80.8% | 82.3% | 82.3% | |
| 83.9% | 87.6% | 86.1% | 81.7% | 79.2% | – | 80.7% | 80.1% | 82.3% | – | 82.4% | 82.4% | |
| 2.9% | – | 0.1% | – | – | – | 2.2% | 1.0% | 0.0% | – | 0.1% | 2.4% | |
| – | – | 1.1% | – | – | – | – | – | 0.2% | – | – | – | |
| 4.6% | – | – | – | – | – | – | – | – | – | – | – | |
| 3.4% | 4.5% | 4.5% | – | – | – | – | – | 0.8% | – | – | – | |
| 30.3% | 34.2% | -67.0% | 6.8% | 6.4% | 5.4% | 5.1% | 4.8% | 6.7% | 11.4% | 13.1% | 13.1% | |
| 18.9% | 15.8% | 15.8% | 5.5% | 5.1% | 4.0% | 3.7% | 3.6% | 5.8% | 10.3% | 11.2% | 11.2% | |
| 1.6% | 2.0% | 2.0% | 0.3% | 0.3% | – | 0.4% | 0.4% | 0.3% | – | 0.6% | 0.6% | |
| – | – | – | – | – | – | – | – | – | – | 2.0% | 2.0% | |
| 69.7% | 65.8% | 67.0% | 93.2% | 93.6% | 94.6% | 94.9% | 95.2% | 93.3% | 88.6% | 86.9% | 86.9% | |
| -217.4% | -318.7% | -318.7% | -495.0% | -548.8% | -604.7% | -617.0% | -626.3% | -469.2% | -511.4% | -591.8% | -591.8% | |
| 17.2% | 3.2% | 3.1% | 4.4% | 5.0% | 88.1% | 39.1% | 39.5% | 0.3% | 101.9% | 49.9% | 50.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.